"Karshen Girmama Kwanaki na Magunguna," The New York Times an bayyana shi a watan Fabrairu na 1985. Labarin ya ba da misali da ƙarin bashin da ake bin doka ya nuna cewa “ba zato ba tsammani manyan kamfanonin magunguna sun shiga cikin irin matsalolin da suka addabi masana’antu marasa kyan gani na shekaru da yawa.” The Times ruwaito, "Ba makawa wasu [kamfanonin] za su fuskanci alhaki masu ban mamaki da kuma dogon shari'o'in kotu kan magungunan da aka amince da su wadanda daga baya suka koma flops."
Daga baya wannan shekarar, a karatun gwamnati tallafi ta masu kera alluran rigakafi, Sojojin Amurka, da Gidauniyar Rockefeller sun ba da shawarar wani shiri na kasa don canja farashin lamunin allurar rigakafin daga Big Pharma zuwa masu biyan haraji na Amurka ta hanyar "shirin kasa mara laifi."
Shekara daya bayan New York Times yayi gargadin cewa alhakin shari'a na barazana ga "kwanakin daukaka" na Pharma, Wyeth da sauran kamfanonin harhada magunguna sun nemi Majalisa ta zartar da Dokar Rauni ta Yara ta Kasa ta 1986 ("NCVIA"), wacce ta tsara shawarwarin binciken gwamnati na Merck. Tun daga lokacin masu biyan haraji sun ɗauki nauyin bashin da aka biya daga samfuran masana'antun masu cin riba.
Idan aka waiwaya baya, kwanakin daukaka ba su fara samun magunguna ba a cikin 1985. Jadawalin rigakafin yara ya fashe daga allurar rigakafin da aka ba da shawarar guda uku (DTP, MMR, da polio) zuwa harbi 72. Kusan shekaru 40, gwamnati ta sami damar ba da umarnin harbe-harbe, tare da ba da garantin biliyoyin daloli na kudaden shiga ga kamfanonin Merck, Pfizer, da sauran masana'antun magunguna, yayin da suke canja farashin kayayyakinsu, ciki har da. matsuguni na daruruwan miliyoyin daloli don raunin rigakafin, akan mai biyan haraji.
Ta yaya kamfanoni masu ƙarfi a cikin ƙasar suka ƙare da garkuwar alhaki don samfuran da suka fi samun riba? Shekaru arba'in, masana'antar harhada magunguna ta sadaukar da ɗaruruwan biliyoyin daloli don zaɓe, hulɗar jama'a, da sarrafa kafofin watsa labarai. Yunkurin ya samu nasarar siyan biyayyar ’yan jarida, da tabarbarewar tsaro daga gwamnatin tarayya, da kuma matsayin da bai dace da tsarin mulki ba sama da ‘yan kasa da ke ba da kudaden gudanar da ayyukansu.
Yayin martanin Covid, Big Pharma ya ji daɗin shekarunsa mafi fa'ida yayin da sauran duniya ke fama da kulle-kulle da rufe makarantu. Kudin shiga na shekara-shekara na Pfizer ya tashi daga dala biliyan 3.8 a 1984 zuwa rikodi $ 100 biliyan a 2022, duk da Dala biliyan 57 daga samfuran Covid. Daga 2020 zuwa 2022, kudaden shiga na Moderna ya karu da sama da kashi 2,000. BioNTech ya samu sama da dala biliyan 30 daga rigakafin Covid-19 a cikin shekaru biyu kacal. Ribar da ta samu ya zarce kashi 75 cikin dari. A cikin 2023, manyan kamfanonin harhada magunguna guda goma suna da haɗin gwiwar kasuwar dala tiriliyan 2.8, wanda ya fi GDP na Faransa girma.
Sayayya na tarayya na Pfizer da Moderna's mRNA Covid alluran rigakafi sun yi yawa fiye da $ 25 biliyan. Gwamnati biya Moderna Dala biliyan 2.5 na kudaden masu biyan haraji don haɓaka rigakafin, da kuma Shugaba Biden kira kan shugabannin kananan hukumomi da su yi amfani da kudin jama’a wajen baiwa ‘yan kasa cin hanci don samun harbe-harbe. Gwamnati ta gabatar da farashin kaya, bincike, da talla; an tabbatar da sayayya; kuma an yi ta kokarin tilastawa mutane masu lafiya nade hannayensu don samun harbin.
Waɗannan sabbin kwanakin ɗaukaka ba su da “babban alhaki” waɗanda a da ke ɗaukar alhakin kamfanoni masu zaman kansu. Jama'a ba za su iya kai ƙarar masana'antun rigakafin rigakafi - gami da Pfizer, Moderna, da Johnson & Johnson - don duk wani lahani da ya haifar daga harbin Covid.
A cikin Fabrairu 2020, Sakataren Lafiya da Ayyukan Jama'a Alex Azar kira ikonsa a ƙarƙashin Dokar Shirye-shiryen Jama'a da Shirye-shiryen Gaggawa (PREP) zuwa bayar da kariya ga abin alhaki ga kamfanonin likitanci don mayar da martani ga Covid. Rahoton Majalisa ya bayyana wannan yana nufin cewa kamfanoni "ba za a iya gurfanar da su don biyan diyya a kotu ba" idan sun fada ƙarƙashin kariyar umarnin Azar.
A cikin shekaru 40 kacal, an yi amfani da tsarin don yi wa kamfanoni hidima da ƴan ƙasa da ba a ba su haƙƙinsu ba. Kamfanoni sun taɓa yin alhakin barnar da suka yi, kuma farashinsu na shari'a haɗari ne na asali a cikin tsarin kasuwa na kyauta. Bayan haka, NCVIA ta haɗu da wannan haɗarin, ta ba da lamuni ga mai biyan haraji. Covid ya shigo da wani mataki na musamman na uku: ribar tarihi ba tare da wani magani na doka don lalacewa ba.
Amurkawa sun ɗauki nauyin samar da samfuran kamfanonin da siyan kayan rigakafin. A sakamakon haka, sun fuskanci hukunce-hukuncen yin harbin kuma sun rasa haƙƙinsu na ɗaukar ikon kasuwanci. Gwamnonin jihohi, kananan hukumomi, da na tarayya sun bukaci ‘yan kasa su zama kwastomomi ga manyan kamfanonin kasar nan a daidai lokacin da suke ba da kariya ga wadanda suka amfana.
Hasashen, kamfanonin harhada magunguna sun yi watsi da alamun gargaɗi daga gwajin asibiti. A watan Yuni 2023, takaddun Pfizer na sirri sun bayyana cewa kamfanin lura sama da miliyan 1.5 mara kyau ga allurar rigakafin Covid, gami da cututtukan jijiyoyin jini 75,000, cututtukan jini 100,000 da cututtukan lymphatic, cututtukan zuciya 125,000, cututtukan haihuwa 175,000, da cututtukan numfashi 190,000. Yawancin waɗannan sun faru ne a cikin samari masu lafiya, tare da 92% na masu ba da rahoto ba su da cututtukan cututtuka. A cikin Janairu 2025, Alex Berenson saukar cewa Moderna ya rufe mutuwar wani yaro mai shekaru kafin makaranta yayin gwajin rigakafinta na Covid mRNA. Duk da bukatun tarayya don bayar da rahoton duk bayanan gwaji, kamfanin ya hana gaskiyar mutuwar yaron daga "kamun bugun zuciya" na shekaru.
To ta yaya hakan ya faru? A cikin kyakkyawan tsari, jami'an gwamnati za su kasance masu kula da hankali, suna ƙin cin hanci da rashawa da yaudara. Maimakon haka, wata kofa mai juyawa ta bayyana tsakanin masana'antar harhada magunguna da hukumomin gwamnati da ke da alhakin sanya ido a kansu. Wannan tsari ya juyar da manufar Kwaskwarimar Kwaskwarimar Bakwai kuma ya haifar da tsarin "kwanakin ɗaukaka" wanda ba a taɓa ganin irinsa ba ga Big Pharma.
Rusa Kwaskwarimar Bakwai
Kwaskwarimar na Bakwai yana ba da tabbacin haƙƙin shari'ar juri a cikin shari'o'in farar hula. A lokacin da aka amince da shi a shekara ta 1791, masu fafutukar neman gyare-gyaren sun nemi kare haƙƙin ƴan ƙasa daga ikon kasuwanci da za su lalata tsarin shari'a don amfanin kansu.
In Manomin Tarayya IV (1787). jãyayya cewa tsarin juri yana da "mahimmanci a kowace ƙasa mai 'yanci" don kiyaye 'yancin kai na shari'a. Idan ba tare da kariyar Kwaskwarima ta Bakwai ba, masu iko - "wanda aka haifa sosai" - za su yi amfani da ikon shari'a, kuma za su kasance "gaba ɗaya, kuma a zahiri ma, don fifita waɗanda suka kwatanta."
Sir William Blackstone ya kira shari'ar juri "darajar dokar Ingila." Kamar Manomin Tarayya IV, shi rubuta cewa rashin juri zai haifar da tsarin shari'a wanda mazaje ke gudanar da su tare da "bias involuntary bias to those of their own rank and mutunci." Ya zama tsakiya ga dalilin juyin juya hali lokacin da Jefferson ya lissafa kin King George III na "fa'idodin shari'a ta juri" a matsayin korafi a cikin Sanarwar 'Yanci.
Shekaru da yawa bayan haka, mun koma tsarin da ke hana 'yan ƙasa damar yin shari'a. An karkatar da tsarin shari'a don amfanin kasuwanci. Ƙofar juyawa tsakanin Big Pharma da gwamnati, tare da kin amincewa da shari'ar da alkalai suka yi, ya haifar da tsarin da masu mulki ke fifita "waɗanda suke da daraja da mutuncinsu."
Majalisa tana jin daɗin haɗin kai da haɗin kai tare da masana'antar harhada magunguna. A cikin 2018, Labaran Lafiya na Kaiser samu "Kusan tsofaffin ma'aikatan majalisa 340 yanzu suna aiki ga kamfanonin harhada magunguna ko kuma kamfanonin da ke neman shiga."
Dangantakar jin daɗi ta ƙara zuwa ga jami'an da ba a zaɓa ba. Alex Azar, Sakataren HHS da ke da alhakin aiwatar da Dokar PREP, shi ne shugaban sashen Amurka na Eli Lilly daga 2012 zuwa 2017. A can, ya lura gagarumin hauhawar farashin magunguna, gami da ninka farashin maganin insulin. Scott Gottlieb ya yi murabus a matsayin Kwamishinan FDA a cikin 2019 shiga Kwamitin Gudanarwa na Pfizer. A lokacin bala'in cutar, Gottlieb ya ba da shawarar kulle-kulle da tantancewa, har ma karfafa Twitter don kashe pro-alurar rigakafin likitocin da suka tattauna rigakafi na halitta.
Mashawarcin Fadar White House Biden Steve Richetti ya yi aiki a matsayin mai fafutuka na tsawon shekaru ashirin kafin ya shiga Gwamnatin Biden. Abokan cinikinsa sun haɗa da Novartis, Eli Lilly, da Pfizer. The New York Times ya kwatanta shi a matsayin "daya daga cikin masu ba da shawara [Biden] masu aminci, kuma wani Mista Biden zai kusan juya zuwa lokacin rikici ko kuma cikin mawuyacin hali."
A cikin Mayu 2023, Shugaba Biden ya sanar da nadin Dr. Monica Bertagnolli a matsayin Darakta na NIH. Daga 2015-2021, Bartagnolli ya karɓi sama da dala miliyan 275 a cikin tallafi daga Pfizer, wanda ya kai kashi 90% na kuɗin bincikenta.
Cin hanci da rashawa ya fi kai tsaye fiye da cin hanci da rashawa. Masana'antar harhada magunguna kai tsaye tana ba da kuɗin kashi 75% na sashin magunguna na FDA saboda "kuɗin mai amfani," ƙimar shawarwarin da aka biya wa hukumar yayin aiwatar da amincewar miyagun ƙwayoyi. "Yana kama da ciniki na shaidan," in ji Dokta Joseph Ross, farfesa a Makarantar Magungunan Yale. "Saboda ya juya… a cikin FDA da gaske tambayar masana'antu, 'Me za mu iya yi don tabbatar da wannan kuɗin?" Sanata Bernie Sanders ya sanya shi mafi sauƙi: "Masana'antar, a wata ma'ana, tana sarrafa kanta."
Haɗin kai tsakanin masana'antar harhada magunguna da gwamnatin Amurka ya haifar da wani tsari na samun riba mai yawa ba tare da lamuni ba. Kamar dai yadda Blackstone yayi gargadin, wannan tsarin shari'a mai cike da rudani yana bawa masu iko damar kebe wadanda suke "mutunsu da mutuncinsu" daga lissafin shari'ar juri.
Sanatan Australiya Gerard Rennick bayyana: "Moderna, kamar Pfizer ko Astra Zeneca (sic), ba su shirye su goyi bayan mantra 'aminci da inganci' ta hanyar rubuta amincin alluran rigakafin ba.
A cikin Agusta 2023, Rennick ya tambayi shugabannin Moderna a Majalisar Dattawan Ostiraliya. "Ba ku shirya rubuta amincin rigakafin ku ba," in ji shi bayyana. Babban jami'in Moderna ya yi ta bijirewa, yana mai ba da amsa cewa "lalata al'amura ne ga masu tsara manufofi."
Amma Big Pharma da gangan sun shigar da kansu cikin tsarin tsara manufofi, tare da yin amfani da matsayin shari'ar juri ta hanyar haɗin kai na sirri da na jama'a. Ta hanyar biliyoyin daloli a cikin lobbying, dokar Corona ta mamaye al'adar doka ta Yamma kuma ta lalata tsarin don kare mafi ƙarfi a cikin al'ummarmu a farashin mai biyan haraji, yana lalata Kwaskwarimar Bakwai da maƙasudin sa a cikin aiwatarwa.
Gangamin Tasiri: Lobbying, Talla, da Yaudara
Pfizer da Big Pharma suna ƙarfafa wannan garkuwar abin alhaki tare da yaɗuwar kamfen ɗin tallace-tallace da lobbying. Daga 2020 zuwa 2022, masana'antar magunguna da samfuran kiwon lafiya ya kashe dala biliyan 1 wajen yin lobbying. Don mahallin, wannan ya fi sau biyar fiye da na banki kasuwanci masana'antu da aka kashe akan lobbying a lokaci guda. A cikin waɗancan shekaru ukun, Big Pharma ya kashe kuɗi fiye da na mai, gas, barasa, cãca, noma, Da kuma tsaro masana'antu hade.
Big Pharma yana ba da ƙarin albarkatu don siyan zukata da tunanin jama'ar Amurka da kafofin watsa labaru, faɗaɗa tasirin tasirin ta hanyar sarrafa bayanan da masu amfani za su iya samu.
Kamfanonin Pharmaceutical kashe kudi sosai akan talla da tallace-tallace fiye da bincike da haɓakawa (R&D) yayin Covid. A cikin 2020, Pfizer ya kashe dala biliyan 12 akan tallace-tallace da tallace-tallace da dala biliyan 9 akan R&D. A wannan shekarar, Johnson & Johnson ya ba da dala biliyan 22 don tallace-tallace da tallace-tallace da dala biliyan 12 ga R&D.
Haɗe, AbbVie, Pfizer, Novartis, GlaxoSmithKline, Sanofi, Bayer, da J&J sun kashe 50% akan talla fiye da R&D a cikin 2020. Suna tallata samfuran magani waɗanda masu amfani ba za su iya samun kansu ba, suna nuna cewa an tsara kashe kuɗi don sarrafa kafofin watsa labarai, ba ƙara tallace-tallacen magunguna ba.
"Mahimmin batu game da tallan kantin magani shine ba sa kashewa don tasiri abokan cinikin da ke kallon labarai. Yana da tasiri ga labarai da kanta," ya bayyana tsohon mashawarcin magunguna Calley Means.
"Pharma na ganin kashe tallace-tallace a matsayin wani bangare na tallan su da kasafin kudin al'amuran jama'a. Hanya ce ta saye hanyoyin sadarwar labarai don yin tasiri a muhawarar."
Kamar yadda aka bayyana, biliyoyin daloli a cikin talla sun haifar da miliyoyin jama'ar Amurkawa shirye-shiryen da Pfizer ke ɗaukar nauyin, ciki har da Good Morning America, CBS Wannan Morning, Ku gana da Latsa, 60 Minutes, CNN Daren Yau, Erin Burnett OutFront, Wannan makon tare da George Stephanopoulos, Anderson Cooper 360, Da kuma ABC Nightline. Galibi, ‘yan jarida sun yi ruku’u a kan tsarin da aka lullube na biyan bashin gidaje na Hudu. A duk lokacin da Covid, the latsa tallata samfuran Big Pharma kuma ba kasafai ake ambaton tarihinta ba arzurta zalunci, zamba, Da kuma roƙon laifi
Wannan shimfidar watsa labarai ta sa Amurkawa ga amincewar karyar jaridun kamfanoni. Shugabannin masu magana da jami'an gwamnati sun yi aiki tare don tallafa wa masu tallafa musu ta hanyar rashin gaskiya.
"A zahiri kawai mutanen da ke mutuwa su ne waɗanda ba a yi musu allurar ba," in ji Chuck Todd ga masu kallonsa. "Kuma masu yada labaran karya daga cikinku ku kunyata ku, ku kunyata ku, ban san yadda wasunku suke barci da dare ba." Zuwa 2022, masu rinjaye An yi wa mutanen da suka mutu daga Covid allurar riga kafi.
Mika Brzezinski ta ɗauki irin wannan hanya kai tsaye ga masu kallonta na MSNBC: "Ku ne marasa rigakafi, ku ne matsalar." Fadar White House, sadaukar da masu kallo na Morning Joe, na'am da muryar Mika. "Mun yi hakuri, amma hakurinmu ya yi kasala," in ji Shugaba Biden a watan Satumba na 2021. "Kuma kin amincewa ya kashe mu duka."
Don Lemon na CNN ya gaya wa Chris Cuomo, "Mutanen da za ku iya zargi - wannan ba abin kunya ba ne, wannan ita ce gaskiya… Jonathan Capehart na MSNBC ya yi wa wadanda ba a yi musu allurar lacca ba, “Duk wanda kuka hadu da shi zai zarge ku, haka ma sauran mu da muka yi abin da ya dace ta hanyar yin allurar.”
"Babu uzuri - babu uzuri ga kowa da ba a yi masa allurar rigakafi," Biden ya tsawatar da 'yan kasarsa a cikin 2022.
Mai ba da gudummawar CNN akai-akai Dr. Leana Wen ta nuna bacin ranta a kan wadanda ba a yi musu allurar ba. "Mutane ba sa nuna hali mai kyau, wadanda ba a yi musu alluran rigakafi ba suna cewa, To, lokacin budewa ne a gare ni." Ta gaya wa masu kallo cewa zabar zama ba a yi musu allurar ba ya yi kama da "zabin tuƙi cikin maye."
a cikin Los Angeles Times, marubuci Michael Hiltzik ya gabatar da kanun labarai: "Mutuwar mutuwar COVID anti-vaxxers abin kunya ne, eh - amma yana iya zama dole."
Howard Stern ya yi kira da a yi musu alluran rigakafin dole kuma ya gaya wa waɗanda ba su yarda da shi ba, "Fuck your 'yancin." Amma Stern ya daina tsokanar gadfly; ya kasance mai magana da yawun hukumomi mafi karfi a kasar, wadanda suka yi maraba da damar da aka ba su na bata dokar kare hakkin bil adama a cikin al'ummar da ba ta da wani abin dogaro.
Ba za a iya kaucewa rashin lafiya ba, Babu shakka ba shi da inganci, kuma ba tare da neman afuwa ba.
Fadar White House ta Biden ta karfafa kamfen na kamfanoni masu zaman kansu, tare da gwabzawa da gwamnatin tarayya biliyoyin ga kamfanonin watsa labarai don tallata rigakafin Covid. A cikin Maris 2022, sa'ĩr ya ruwaito:
"A mayar da martani ga bukatar FOIA da TheBlaze ta gabatar, HHS ta bayyana cewa ta sayi tallace-tallace daga manyan hanyoyin sadarwar labarai ciki har da ABC, CBS, da NBC, da kuma tashoshin labarai na TV na Fox News, CNN, da MSNBC, wallafe-wallafen kafofin watsa labarai na gado ciki har da New York Post, Los Angeles Times, da Washington Post, kamfanonin watsa labaru na dijital kamar BuzzFeed Newsmax da Newsmax, waɗannan jaridu na gida da kuma ɗaruruwan gidajen talabijin na da alhakin tattara Labarai da Newsmax. buga labarai marasa adadi da sassan bidiyo game da allurar da suka yi kusan daidai game da maganin dangane da ingancinsa da amincinsa. "
"Lafiya kuma mai tasiri" ya zama mai maimaitawa akai-akai a cikin shimfidar watsa labarai wanda 'yan kaɗan suka damu don bincika ko alamar ta gaskiya ce. Taken ya ci karo da dogon fahimtar hadarin da ke tattare da shi. A cikin 1986, Kwamitin Makamashi da Kasuwanci na Majalisar ya ba da rahoto wanda ya bayyana alluran rigakafi a matsayin "marasa lafiya wanda ba zai yuwu ba." Kotun Koli ta ba da misali da shawarar "marasa lafiya wanda ba zai yuwu ba", kwatanta samfuran "a halin da ake ciki na ilimin ɗan adam," kamar yadda "ba za a iya samun aminci don amfanin da aka yi niyya da na yau da kullun ba."
Bugu da ari, babu wata shaida da ta nuna cewa harbe-harbe suna "tasiri." A Nazarin Pfizer ya nuna cewa kashi 20 cikin 1 na wadanda suka sami allurar rigakafin Covid na kamfanin sun sami Covid cikin watanni biyu, yayin da kashi XNUMX% na mahalarta gwajin sun ba da rahoton "cututtukan zuciya" bayan harbin farko da suka yi. Shuwagabannin kamfanin sun yarda a karkashin shedar rantsuwa cewa kamfanin bai taba gwada ingancin allurar rigakafin kamuwa da cutar ba kafin tallata su.
A watan Oktoban 2022, mai magana da yawun Pfizer Janine Small ta bayyana a wani taron Majalisar Turai. "Shin an gwada maganin Pfizer Covid akan dakatar da yada kwayar cutar kafin ta shiga kasuwa?" ya tambayi MEP dan kasar Holland Rob Roos. "A'a!" Karami amsa da jajircewa. "Dole ne da gaske mu matsa cikin saurin kimiyya don fahimtar ainihin abin da ke faruwa a kasuwa; kuma daga wannan ra'ayi, dole ne mu yi duk abin da ke cikin haɗari."
“Hadarin” ya bayyana yana da yawa. Kwanaki kafin shaidar ƙarami, Babban Likitan Likita na Florida Joseph Ladapo saki Binciken da ke nuna karuwar 84% a cikin alaƙar mutuwar da ke da alaƙa da zuciya a cikin maza 18-39 a cikin kwanaki 28 na rigakafin mRNA.
Nan da Yuni 2021, Tsarin Ba da Rahoto Mai Kyau mai Kyau (VAERS) ruwaito Mutuwar 4,812 daga rigakafin Covid da kuma asibitoci 21,440. Domin mahallin mahallin, VAERS ya ba da rahoton mutuwar mutane 5,039 ne kawai daga duk sauran rahotannin rigakafin da aka haɗa tun 1990. A cikin Janairu 2023, VAERS wuce Mummunan al'amura miliyan daya da aka ruwaito daga allurar Covid da kuma mutuwar 21,000, tare da kashi 30% na wadanda suka mutu sun faru a cikin sa'o'i 48 na rigakafin. Hukumar Kula da Magunguna ta Turai nasaba Alurar rigakafin cutar zuwa ga gurɓataccen fuska, ɓacin rai, tausasawa, da tinnitus. The CDC daga baya ya yarda cewa harbin yana da alaƙa da kumburin zuciya (myocarditis), musamman a cikin samari, da kuma ciwon Guillain-Barre da kuma zubar jini.
Dokta Buddy Creech, mai shekaru 50, ya jagoranci gwajin rigakafin Covid a Jami'ar Vanderbilt kafin ya haɓaka tinnitus da tseren zuciya bayan samun harbin. Creech ya ce tinnitus da bugun zuciyarsa sun kasance kusan mako guda bayan kowane harbi. "Lokacin da majinyatan mu suka sami wani sakamako na gefe wanda maiyuwa ko ba ya da alaƙa da allurar, muna bin su da su bincika hakan gaba ɗaya gwargwadon yadda za mu iya," in ji shi. ya gaya da New York Times.
"Lafiya kuma mai inganci" ya zama taken tallan magunguna da aka yi wa lakabi da 'yan jaridu wanda ya dogara da ci gaba da samun kudaden shiga na talla daga kamfanonin da ke rufewa. Gwamnatin Amurka ta kuma shiga cikin rufa-rufa a yakin sa-in-sa da take yi don yiwa 'yan kasar da dama da dama.
A Janairu 2024, Zaman Epoch saukar cewa CDC ta tsara “ faɗakarwa kan rigakafin myocarditis da mRNA ”a cikin Mayu 2021 ga jami’an jihohi da na gida, tare da yi musu gargaɗi game da alaƙa tsakanin kumburin zuciya da harbin Covid-19. Marubucin rahoton, Dokta Demetre Daskalakis, tabbas ya yanke shawarar kada ya bayyana sakamakon bincikensa.
Daga baya CDC ta aika da maimaita faɗakarwa da ke ƙarfafa rigakafin Covid-19 amma ba ta buga gargaɗin ta akan myocarditis ba. Dr. Tracy Hoeg, wata kwararriyar cutar ta California, ta shaida wa Epoch Times, "Muna da bayanai daga Ma'aikatar Tsaro ta mu a wannan lokacin da ke nuna alamar aminci ce ta gaske kuma an riga an ba da rahoton bullar cutar myocarditis bayan Pfizer guda biyu a Isra'ila."
Lokacin da Daskalakis ya tsara faɗakarwar, yawancin matasan Amurka ba su sami harbin Covid ba. Babu wata jiha da ke da adadin rigakafin sama da kashi 14 na yara masu shekaru 12 zuwa 17. A California, kashi 90% na wannan rukunin shekarun ba a yi musu rigakafi ba. A cikin shekaru biyu masu zuwa, CDC ba ta taɓa buga faɗakarwarta ba, kuma ƙasar ta yi wa miliyoyin matasa allurar. A cikin shekaru biyu, 84% na matasa California suna da aƙalla kashi ɗaya na maganin Covid; fiye da ɗaya cikin biyar sun sami ƙarfafawa.
Yaƙin neman zaɓe na Big Pharma ya wuce fagen watsa labarai. An daɗe ana kallon mujallolin likitanci ga bukatun kamfanoni. Tun daga shekarar 2017, rabi na editocin mujallolin likitancin Amurka suna karɓar kuɗi daga kamfanonin magunguna. Kamfanoni suna biyan likitocin su jera kansu a matsayin mawallafa don haɓaka amincin rahotannin su a cikin wani tsarin aka sani da "likitan fatalwa-rubutun."
Da zarar rigakafin Covid ya zo tare, Pfizer kungiyoyin biya to inganta alurar rigakafi ga ma'aikata. A cikin watan Agusta 2021, Shugaban Kungiyar Birane na Chicago Karen Freeman-Wilson ya ba da sanarwar tallafin kungiyar don umarnin rigakafin Covid. Ba ta bayyana cewa ƙungiyar ta ta sami tallafin dala 100,000 daga Pfizer don ƙaddamar da "kamfen ɗin aminci da inganci na rigakafin rigakafi." Makonni bayan haka, Kungiyar Masu Kasuwa ta Kasa ta ba da sanarwar, "Ya zama shaida cewa umarnin ma'aikata na da tasiri wajen jawo mutanen da ba su son samun rigakafin Covid-19." A watan da ya gabata, Pfizer ya ba kungiyar $75,000 don "kokarin manufofin rigakafin." Kwalejin Ilimin Ilimin Yara na Amurka tana da ɓangarorin ɓangarorin gida don manufofin jihar na rigakafin rigakafi bayan sun karɓi $250,000 daga Pfizer, gami da tallafin shawarwarin “dokokin rigakafi”.
Sauran ƙungiyoyin da suka haɓaka umarni bayan sun sami tallafin Pfizer sun haɗa da Ƙungiyar Masu Amfani da Ƙasa, Ƙungiyar Magunguna ta Amirka, Kwalejin Magungunan Rigakafin Amirka, Ƙungiyar Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Amirka. Babu ɗayansu da ya bayyana abubuwan da suka sa kuɗi.
Akwai hadadden dabarun hulda da jama'a don kamfanonin harhada magunguna don kiyaye matsayinsu na kariya na masu cin riba na doka. Ba wai kawai sun sayi biyayyar kafafen yada labarai ba, har ma sun yi amfani da tilastawa kudi don tabbatar da cewa cibiyar likitocin ba ta da ikon yin adawa da su.
Bayan fitowar Rahoton Shekara-shekara na Pfizer na 2022, Shugaba Albert Bourla ya jaddada muhimmancin abokin ciniki ta "tabbataccen hasashe" na Pharmaceutical giant.
"2022 shekara ce da ta samu karbuwa ga Pfizer, ba wai kawai ta fuskar kudaden shiga da abin da aka samu a kowace kaso ba, wadanda suka kasance mafi girma a cikin dogon tarihinmu." Burla ya lura. "Amma mafi mahimmanci, dangane da adadin marasa lafiya waɗanda ke da kyakkyawar fahimta game da Pfizer da aikin da muke yi."
Masana'antar ta sadaukar da biliyoyin daloli wajen murde Amurkawa wajen daukar kayayyakinta yayin da gwamnatinsu ta kwace musu hakkinsu na shari'a; 'yan kasa, ba tare da ikon yin la'akari da kamfanoni a gaban kotu ba, ci gaba da bayar da tallafi gwamnatin tarayya-pharmaceutical hegemon tare da harajin dalar su.
Hasali ma, gwamnatin tarayya ta sayar da gyare-gyare na bakwai ga babbar rundunar masu fafutuka a kasar. Wannan ya mayar da mulki daga ƴan ƙasa zuwa masu mulki na ƙasa kuma ya yi musayar haƙƙin tsarin mulki don garkuwar abin alhaki na kamfani.
Shiga cikin tattaunawar:
An buga ƙarƙashin a Commonirƙirar Commonabi'a Mai Creativeayatarwa 4.0 Licenseasashen Duniya
Don sake bugawa, da fatan za a saita hanyar haɗin yanar gizo zuwa asali Cibiyar Brownstone Labari da Marubuci.
